Fussenegger, Martin, Prof. Dr.

ETH Zürich Prof. Dr. Martin Fussenegger Department of Biosystems Science and Engineering (D-BSSE) WRO-7.62 Mattenstrasse 26 4058 Basel Switzerland Phone: +41 61 387 31 60 Fax: +41 61 387 39 88 E-Mail:

Martin Fussenegger is professor of biotechnology and bioengineering at the Department of Biosystems Science and Engineering in Basel (D-BSSE) of the Swiss Federal Institute of Technology, the ETH Zurich. In 1992 he graduated in molecular biology and genetics with Werner Arber at the Biocenter in Basel, joined the Max Planck Institute of Biology for his Ph.D. thesis in medical microbiology (1993-1994) and continued his studies on host-pathogen interactions at the Max Planck Institute of Infection Biology as a postdoctoral fellow (1995). In 1996, Martin Fussenegger joined the research unit of James E. Bailey at the ETH Institute of Biotechnology as an independent group leader where he refocused his research on mammalian cell engineering, a topic for which he received his habilitation in 2000. In 2002 Martin Fussenegger became Swiss National Science Foundation professor of molecular biotechnology at the ETH Institute of Biotechnology prior to being awarded a chair in biotechnology and bioengineering at the ETH Institute for Chemical and Bioengineering (2004). Since 2006, Martin Fussenegger is director of studies of the ETH biotechnology curriculum and director of the ETH Institute for Chemical and Bioengineering.

Martin Fussenegger has published over 165 refereed research papers, is coinventor of several patents, Vice-Chairman of the European Society for Animal Cell Technology (ESACT), editor of the Journal of Biotechnology, editorial board member of Cell Engineering and Biotechnology & Bioengineering and cofounder of the biotechnology startup companies Cistronics Cell Technology GmbH and Cistronics Antiinfectives AG. For his contributions to drug discovery and cell engineering Martin Fussenegger received the de Vigier and the Elmar Gaden Awards in 2003, became a member of the American Institute for Medical and Biological Engineering in 2007 and was the first non-US recipient of the Merck Award in Cell Engineering in 2008.